StockWatch
·
INDIAN BANK · Q2 FY2027 · THE VERDICT

Deposits and Advances Beat, But Earnings Growth Is an Illusion

Indian Bank beat revised guidance on deposits and advances, but reported profit growth of 13.4% includes a ₹1,134-crore NSE listing gain; adjusted, growth drops to ~8%. The quarter shows strong balance-sheet momentum masking earnings headwinds and one-time boosts.

Q2 FY27 resultsINDIANBINDIAN BANK21 Oct 2026 · 6 min read
Reported PAT

₹3,447 Cr

+13.4% YoY

NSE MTM gain

₹1,134 Cr

one-time inflator

Adjusted PAT

~₹2,313 Cr

+~8% YoY organic

Indian Bank's Q2 result looks strong on the headline—revenue up 15.2%, PAT up 13.4%—but beneath the surface, the quarter is a study in separating noise from signal. Reported profit includes a ₹1,134-crore mark-to-market gain from the NSE listing, a one-time windfall that inflates organic earnings growth to just 8%. That gap, between headline growth and adjusted growth, is the story of the quarter.

Where the profit really came from

Of ₹3,447 crore in reported PAT, approximately ₹1,134 crore came from the NSE listing mark-to-market gain, with an additional ₹252 crore from NSE share sales—a combined ₹1,386 crore contribution. Excluding these, core PAT would be roughly ₹2,313 crore, growing at ~8% year-on-year. For context, management's operating profit headline grew 46.58%, but ex-NSE, growth was a more modest 18%. The bank's own commentary acknowledged this: treasury income is not expected to persist, and the ECL provision jump (₹1,500 crore this quarter, ₹3,500 crore total expected) will further depress near-term earnings.

Q2 FY27 Profit Attribution, ₹ Cr
01,286.882,573.763,860.643,447Reported PAT1,134NSE MTM2,313Adjusted PAT
NSE gain is 33% of reported PAT. Organic PAT growth drops from 13.4% to ~8% when adjusted.

The deposit and advance beat—substance here

Where Indian Bank delivered real substance: deposit growth of 12.5% year-on-year beat the revised guidance range of 11–12%, and advances growth of 16.39% significantly outpaced the 13–14% revised guidance. This is not an optical win—the bank raised guidance at the Q1 call and beat both metrics on the back of genuine business momentum. Retail advances grew 17.37%, agriculture 17.18%, and MSME 19.06%, while corporate lagged at 9.92% (the bank is targeting a ramp from 1–2% to 10–12% via capacity building and credit training). Deposits benefited from ₹21,000 crore in FCNR(B) inflows, though bulk deposits actually fell ₹10,000 crore, signaling a funding mix shift. Credit quality held firm: gross NPA came in at 1.61%, precisely at the upper end of the 1.50–1.60% guidance band, with slippage improving 8 basis points quarter-on-quarter to 0.69%.

What changed on this call

Management upgraded both deposit growth guidance (from 9–11% to 11–12%) and advances guidance (from 11–13% to 13–14%), signalling confidence in the deposit franchise and business momentum. However, two material recalibrations were delivered less ceremoniously. First, credit cost guidance was reset lower: the prior 1% full-year guidance is now being normalized to 10–15 basis points going forward—not a miss, but a significant downward pivot that signals lower provision income ahead. Second, NIM expansion, while expected to continue at 5–6 basis points this quarter, is being constrained by deposit repricing lag; management explicitly cautioned that bulk deposit costs are still repricing upward despite the RBI's 25-basis-point rate hike, capping upside. In corporate, a capacity-building initiative aims to ramp growth from 1–2% historically to 10–12% forward, a longer-term bet rather than an immediate driver.

Key claims on the call, validated against delivery

Total business grew 14.22%

Delivered advances growth 16.39%, deposits growth 12.50%—strong, but mix is skewed to higher-growth retail/MSME, corporate lagging.

Supported

PAT grew 14.71% to ₹3,447 Cr

Includes ₹1,134 Cr NSE MTM gain. Adjusted PAT growth ~8%, not 14.7%.

Overstated

Operating profit grew 46.58%

Includes NSE contribution. Excluding NSE, operating profit grew 18%—material but not exceptional.

Overstated

NIM improved 8 bps YoY

Domestic NIM +1 bp, global NIM +2 bps QoQ. YoY improvement supported, but magnitude subject to deposit repricing lag. Forward expansion capped at 5–6 bps.

Supported, but capped ahead

Advances grew 16.39% (17–19% by segment)

Retail 17.37%, agri 17.18%, MSME 19.06%, corporate 9.92% (lower). Growth outpaced guidance.

Supported

Gross NPA declined to 1.61%

At upper end of 1.50–1.60% guidance. Slippage down 8 bps QoQ. Asset quality solid but at ceiling.

Supported

Credit cost 0.22%, well below 1%

Delivered 0.22%. Management now guiding 10–15 bps forward (new normal), not full 1%—material recalibration.

Supported, but guidance reset lower

The bull-bear ledger

  • Deposit and advance growth beat revised guidance by 140–240 bps respectively

  • Retail credit quality strong: 92% of book has CIBIL score above 750

  • Asset quality stable; NPA at guidance ceiling, slippage improving

  • CASA ratio 39.36% on track; target 40% nearly achieved

  • Reported profit growth of 13.4% is inflated by ₹1,134 Cr NSE one-time; adjusted growth only 8%

  • NIM expansion capped at 5–6 bps by deposit repricing lag; bulk deposits still repricing upward

  • Credit cost recalibrated from 1% to 10–15 bps; ECL provisions (₹1,500 Cr this Q, ₹3,500 Cr total) will depress earnings 1–2 years

  • Management targeting 'balanced' 16–17% growth vs industry 20–25%; explicit caution on competitive pressure in housing (<7% yields) and corporate (<8.36% yields)

Ranked risks: what holders should worry about

Top risks ordered by severity and impact on the holder

HTM portfolio revaluation (April 1, 2027)

High

60–74% of the investment portfolio will be marked to market on April 1. If the 10-year GSec yield stays at 7.41%, material reserves will be required. RBI guidelines on phasing are not yet finalized. Potential shock to equity, capital adequacy, and dividends.

ECL provision normalization

High

₹1,500 crore ECL provision this quarter, ₹3,500 crore total impact expected over 1–2 years. Will suppress net profit growth until models stabilize. Management acknowledges this is one-time but not quantifying the quarterly phasing.

NIM expansion capped by deposit repricing lag

High

25-bps RBI rate hike, but deposit costs are repricing faster than lending yields benefit. NIM expansion limited to 5–6 bps. Bulk deposits still repricing upward; benefit accrues over 6–12 months. Constrains margin expansion and profit growth.

Competitive lending intensity

Medium

Housing loans yielding <7%, corporate loans <8.36%. Competitors pursuing volume over quality. Bank defending growth at 16–17% vs industry 20–25%, but pricing power is limited. If recession hits, competitive pressure could force margin compression.

Corporate growth ramp unproven

Medium

Management targeting 10–12% corporate growth (vs 1–2% prior) via capacity building and credit training. This is a new initiative with unproven execution. If ramp fails, overall growth target (16–17%) will miss.

FCNR(B) deposit rollover and currency risk

Low

Raised ₹21,000 crore FCNR(B) deposits; 90–96% deployed to USD-denominated loans. Deployment limit reached. If FCNR(B) inflows slow, bulk deposit repricing pressure will intensify.

The street's view: price, flows, positioning

The market's initial reaction was modest: a +2.29% pop on day 1 after the result announcement, with 58.3% delivery (a solid technical signal, but not euphoria). Since then, the stock has pulled back; it trades at ₹859, which is -12.35% off its all-time high of ₹980 and still above its 20-day (₹827), 50-day (₹854), and 200-day (₹855) moving averages—a neutral-to-slightly-bullish technical setup. RSI sits at 57.2, indicating neither overbought nor oversold. Ownership data shows FII ownership at 6.16% (up 34 basis points quarter-on-quarter), signaling modest institutional confidence, while DII ownership fell slightly to 17.03% (down 72 basis points), and the promoter remains anchored at 73.84%. The dual message: foreign institutions are buying, domestic institutions are trimming. This makes sense—the result beat on balance-sheet strength (deposits, advances) but disappointed on earnings quality (NSE inflation) and forward guidance (NIM capped, ECL headwind). The post-result bounce was justified (beat the revised guide), but the subsequent fade reflects the market pricing in the earnings headwinds ahead.

What to watch next
  • 1 · Q3 NIM and deposit repricing trajectory

    Management guided 5–6 bps NIM expansion this quarter and cautioned on bulk deposit repricing lag. Watch whether the 25-bps rate hike starts accruing to MCLR-linked advances (43% of the book) and whether bulk deposit costs stabilize. If deposit repricing accelerates, NIM could surprise to the upside.

  • 2 · ECL provision trajectory and credit cost

    The ₹1,500 crore ECL provision this quarter is the first step of a ₹3,500 crore total impact. Watch the quarterly phasing and whether SMA book deterioration accelerates credit cost beyond the 10–15 bps guidance. SMA is down from 7.35% to 4.19%, a positive signal.

  • 3 · Corporate growth capacity ramp execution

    The bank targets corporate advances growth of 10–12% forward (vs 1–2% historically) via credit training and pipeline building. Q2 delivered 9.92% corporate growth, below the overall 16.39%. Watch whether capacity-build initiatives yield results in Q3–Q4.

  • 4 · HTM revaluation and RBI guidance (April 1, 2027)

    The biggest unknown: HTM portfolio (60–74% of investments) will transition to market valuation on April 1, 2027. RBI guidance on phasing and reserve requirements is not yet finalized. Watch for any early RBI communication on relief or phasing.

Indian Bank delivered a steady quarter, not a step-change. Deposit and advance momentum is genuine, beating revised guidance decisively. But earnings growth is an illusion—reported PAT growth of 13.4% drops to ~8% when adjusted for the NSE listing windfall, a material one-time that will not repeat. Management is being cautious: explicitly targeting 'balanced' 16–17% growth rather than chasing the industry's 20–25%, acknowledging competitive pressures in housing and corporate lending. The near-term outlook is headwinds: NIM expansion capped at 5–6 bps by deposit repricing lag, credit cost recalibrated lower, and ECL provisions to depress earnings over the next 1–2 years. The Q4 wild card is the HTM portfolio revaluation on April 1, a potential shock to equity if RBI does not phase in the mark-to-market requirement.

Verdict: Hold. The fundamental case is 'slow and steady,' with franchise strength offset by near-term earnings headwinds. For growth investors, the constrained NIM and capped credit cost offer little upside. For yield investors, the deposit growth and credit quality are reassuring. The single number to track from here is adjusted net profit growth—management's ability to grow earnings without one-time props, a figure that will settle around ₹2,300–₹2,400 crore adjusted run-rate once ECL stabilizes. Until then, the stock is priced fairly for a mid-sized PSB executing with discipline but limited near-term growth.

Informational and educational content only. Not investment advice.